To investigate the frequency of IL-35-producing B cells in the peripheral blood of GC patients, we first gated B cells with the B cell surface marker CD19 and then used the EBI3+p35+ marker to identify IL-35-producing B cells (Fig. 1A). This evidence concerns the gene CD19 and gastric cancer.